Products

Online Inquiry

As a CRO specializing in cardiovascular disease research, Ace Therapeutics offers a range of inhibitors & activators to study and understand the mechanisms underlying various cardiovascular conditions. These compounds play a crucial role in drug discovery and the development of potential therapies.

Inhibitors & Activators

Nisoldipine-d6 (CDIA-1992) Inquiry
Formula:
C20H18D6N2O6
CAS Number:
1285910-03-3
Molecular Weight:
394.45

Guanfacine-d2 hydrochloride (CDIA-1993) Inquiry
Formula:
C9H8D2Cl3N3O
CAS Number:
1398065-88-7
Molecular Weight:
284.57

Lisinopril-d5 (CDIA-1994) Inquiry
Formula:
C21H26D5N3O5
CAS Number:
1356905-39-9
Molecular Weight:
410.52

Metoprolol-d7 (CDIA-1995) Inquiry
Formula:
C15H18D7NO3
CAS Number:
959787-96-3
Molecular Weight:
274.41

Simvastatin-d11 (CDIA-1996) Inquiry
Formula:
C25H27D11O5
CAS Number:
1002347-74-1
Molecular Weight:
429.63

Atopaxar hydrobromide (CDIA-1998) Inquiry
Formula:
C29H39BrFN3O5
CAS Number:
474550-69-1
Molecular Weight:
608.54

Metoprolol (fumarate) (CDIA-2000) Inquiry
Formula:
C34H54N2O10
CAS Number:
80274-67-5
Molecular Weight:
650.80

F15845 (CDIA-2001) Inquiry
Formula:
C20H25NO2S2
CAS Number:
470454-73-0
Molecular Weight:
375.55

Cilnidipine-d7 (CDIA-2002) Inquiry
Formula:
C27H21D7N2O7
Molecular Weight:
499.56

Avanafil-13C, d3 (CDIA-2003) Inquiry
Formula:
C2213CH23D3ClN7O3
Molecular Weight:
487.96

! For research use only. Not intended for any clinical use.